Aprea Therapeutics, Inc. (APRE) |
| 0.8926 -0.038 (-4.07%) 05-29 16:00 |
| Open: | 0.93 |
| High: | 0.9435 |
| Low: | 0.8881 |
| Volume: | 123,760 |
| Market Cap: | 6(M) |
| PE Ratio: | -0.6 |
| Exchange: | NASDAQ Global Select |
| Industry: | Biotechnology |
| Sector: | Healthcare |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 1.06 |
| Resistance 1: | 0.95 |
| Pivot price: | 0.91 |
| Support 1: | 0.77 |
| Support 2: | 0.64 |
| 52w High: | 2.22 |
| 52w Low: | 0.548 |
Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel cancer therapeutics that target DNA damage response pathways. Its lead product candidate is ATRN-119, an oral ATR inhibitor that is in phase 1/2a clinical trial to treat patients with advanced solid tumors. The company's products pipeline also includes ATRN-Backup, an ATR inhibitor; ATRN-W1051 to treat anti-tumor activity; and ATRN-DDRi. Aprea Therapeutics, Inc. is based in Boston, Massachusetts.
Financials
| EPS | -12560000.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | -62.675 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | -10.00 |
| Return on Assets (ttm) | 202.0 |
| Return on Equity (ttm) | -23.2 |
Company news
Fri, 22 May 2026
Aprea Therapeutics (APRE) upgraded to buy: Here's what you should know - MSN
Fri, 15 May 2026
Vestal Point reports 9.9% stake in Aprea Therapeutics (NASDAQ: APRE) - Stock Titan
Thu, 14 May 2026
Press Release: Aprea Therapeutics Reports First Quarter 2026 Financial Results and Provides a Corporate Update - Moomoo
Wed, 13 May 2026
APREA THERAPEUTICS ($APRE) Releases Q1 2026 Earnings - Quiver Quantitative
Wed, 13 May 2026
Aprea Therapeutics Releases Q1 2026 Financial Results - AlphaStreet
Wed, 13 May 2026
Aprea Therapeutics Closes Oversubscribed $30 Million Private Placement to Advance APR-1051 Development and Reports Positive Early Data from Phase 1 Trial - Quiver Quantitative
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
